1. Introduction {#sec1}
===============

In 2010, it was estimated that there were 39 million people blind globally, with 51% being attributed to cataract \[[@B1]\]. In particular, the female population accounts for approximately 60.0% of blindness and 57% of moderate-to-severe visual impairment \[[@B2]\]. South Asia, which accounts for 24.6% of the world\'s population, has undergone fundamental transitions in society and economic development over the past two decades. Although this region has achieved significant progress in blindness prevention, it still accounts for 32.7% of the world\'s blind population in 2010 \[[@B2]\]. In addition, the expansion rate of the blinded population was 4 times higher in females than that in males (16.1% versus 3.7%) from 1990 to 2010, which poses significant public health concerns \[[@B2], [@B3]\]. Cataract remains the leading cause of blindness, which accounts for 41.7% blindness in this region in 2010 \[[@B3]\].

Cataract blindness can be cured by a straightforward and cost-effective procedure. Economic analysis demonstrates that cataract surgery led to substantial improvements in quality of life, increases in income, and alleviation of poverty \[[@B4]--[@B7]\]. The financial return on investment of the first-eye cataract surgery was estimated to be 4567% over the 13-year model in the United States \[[@B8], [@B9]\]. Cataract surgical coverage (CSC) was recommended by the World Health Organization (WHO) for evaluating the accessibility and utilization of cataract surgical services in a given district. It was endorsed by the Global Action Plan (GAP) to assess and monitor the national eye service. CSC indicates the percentage of cataract surgeries and cataract surgical needs of the population, which reflects the actual community level situation.

Several years ago, the WHO and other nongovernment organizations (NGOs) introduced the VISION 2020 program to reduce the burden of vision loss worldwide. Considering the disproportionately high level of blindness in females, concerns over gender inequality were emphasized as the theme of the World Sight Day in 2009: Gender and eye health: equal access to care \[[@B5]\]. In a meta-analysis conducted 2 decades ago, Abou-Gareeb et al. reported that the chance of blindness in developing countries was 1.3 times higher in females compared to males \[[@B2], [@B10]\]. Previous anecdote meta-analysis indicated that the female gender was a barrier to the access of cataract surgery \[[@B11], [@B12]\]. However, limited studies were included in these analyses and the state of gender inequalities in access to cataract surgical services in South Asia is not well understood. Therefore, a systematic review and meta-analysis of population-based cross-sectional studies were performed to assess whether the female gender remains a significant barrier to access of cataract surgery in South Asia in the past two decades.

2. Materials and Methods {#sec2}
========================

The protocol of this study was registered on the International Prospective Register of Systematic Reviews (CRD42017054426). This systematic review and meta-analysis were performed in accordance with the PRISMA statement (<https://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017054426&ID=CRD42017054426>) \[[@B13], [@B14]\]. Literature searches, study selection, and data extraction were conducted by two independent reviewers (QY and YC). Any disagreements were resolved by discussion and consulting a third senior reviewer (WW) if needed.

2.1. Data Sources and Searches {#sec2.1}
------------------------------

A systematic literature search was performed in Pubmed, [Embase.com](http://Embase.com), and ISI Web of science from Jan 2000 to Jan 2019. The common keywords related to cataract surgery, cataract surgical coverage (CSC), population-based studies, and country names were used. The search strategy is detailed in [Appendix 1](#secA){ref-type="sec"}. No language restriction was imposed. The Google Scholar Engine, Rapid Assessment of Avoidable Blindness (RAAB) repository (<http://raabdata.info/repository/>), and WHO website (<http://www.who.int/en/>) were also used to identify eligible studies. The reference lists of the included articles and related reviews were also screened to identify additional eligible studies.

2.2. Study Selection {#sec2.2}
--------------------

Studies were included for analysis if they met the following criteria: (1) they were performed after 2000; (2) the study design was population-based or in the form of RAAB, national registry, or national/subnational survey of all populations; (3) the study was conducted in a general adult population; (4) the study reported the number of cataract surgery performed (person/eyes) and the number requiring cataract surgery (person/eyes) at visual acuities of \<3/60 (20/400) or 6/18 (20/60), or provided the data needed to calculate them. To eliminate the bias by refractive errors, only the corrected or pinhole visual acuity was used for calculating CSC. For the same population with several studies performed at different times, only the latest one was included. For the same studies with multiple publications, only the most complete was included and the others were referenced for data extraction as needed. Hospital-based studies, studies in special settings such as leprosy villages, meeting abstracts, and studies with insufficient data were not included.

2.3. Data Extraction {#sec2.3}
--------------------

For each study, the following information was collected: first author\'s name, year of publication, study design, location, characteristics of subjects, number of people receiving examinations, response rates, CSC by sex based on persons and eyes at different visual acuity cutoff, the number of persons/eyes operated, and the number of persons/eyes needing cataract surgery. CSC can be calculated at a per-person level or a per-eye level based at different visual acuity levels (\<3/60, 6/60, and 6/18). For eyes, CSC is calculated as (*a*/(*a* + *b*)) × 100, where *a* = number of (pseudo)aphakic eyes and *b* = number of eyes with operable cataract (BCVA\<3/60; \<6/60; \<6/18). For a person, CSC is calculated as ((*x* + *y*)/(*x* + *y* + *z*)) × 100, where *x* = persons with bilateral (pseudo)aphakia, *y* = persons with 1 (pseudo)aphakic and 1 operable cataract, and *z* = persons with bilateral operable cataract at different VA levels \[[@B15]\]. The two extreme cutoffs (3/60 and 6/18) were used in this study.

Many studies did not report raw data for calculating CSC and its 95% confidence interval (95% CI). To address this, we followed the methodology of previous meta-analysis by Lewallen et al. \[[@B11], [@B12]\]. For studies without raw data but reporting CSC by sex and their 95% CI, we calculated backwards to estimate the denominator (N), which equals to the sum of operated persons (eyes) and the number of persons (eyes) requiring cataract surgery. The following function was used: *N* = 1.96^2^ × 100 × CSC × (100 − CSC)/(CSC − lower 95% CI)^2^. The number of operated persons (eyes) and the number of persons (eyes) requiring cataract surgery were calculated based on *N* and CSC at a specific level. For studies providing both raw data and CSC with 95% CI, the former was used in the meta-analysis.

2.4. Assessment of Risk and Bias {#sec2.4}
--------------------------------

The methodological quality of the included studies was assessed using a risk and bias tool in prevalence studies \[[@B16]\]. It consists of ten items related to the representativeness of the sample, the sampling technique, risk of nonresponse bias, the data collection method, the case definition, the ascertainment toll, and the statistical method. Each item was scored 1 or 0 to represent a "low risk of bias" or "high risk of bias." The total score ranged from 0 to 10 with 0--3 for high risk, 4--7 for moderate risk, and 7 and greater for low risk.

2.5. Data Synthesis and Statistical Analysis {#sec2.5}
--------------------------------------------

Three methods were used to summarize the impact of the female gender on CSC. First, for each study, the respective CSC for males and females was used to calculate an OR using the formula OR = CSC~male~ × (100 − CSC~female~)/((100 − CSC~male~) × CSC~female~) \[[@B11]\]. Then, the weighted average (mean) OR of these ORs was calculated based on sample sizes in each study. Second, a meta-analysis was performed using raw data to calculate the pooled ORs based on person (eyes) at a visual acuity of \<3/60 and 6/18. Third, a pooled relative risk was calculated and used to estimate the blindness (visual acuity\<3/60) population-attributable risk percentage (ARP) using the formula ARP = *P* × (RR − 1)/\[*P* × (RR − 1) + 1\], where *P* = proportion of female in adults population, estimated at 55% \[[@B11]\]. Statistic heterogeneity between studies was tested using Cochran\'s *Q* and *I*^2^ statistics, which was considered significant when *P* \< 0.10 and/or *I*^2^ ≥ 50% \[[@B17]\]. A random effect model was used. Subgroup analysis was performed by study design and location type. Sensitivity analysis was also performed using single-study influence analysis. The potential publication bias was assessed using Begg\'s tests and Egger\'s test \[[@B18]\]. All analyses were performed using STATA version 12.0 (Stata Corp). A *P* value \< 0.05 was considered significant, except where otherwise specified.

3. Results {#sec3}
==========

3.1. Literature Search {#sec3.1}
----------------------

[Figure 1](#fig1){ref-type="fig"} shows the process of the study selection. After the title and abstract review, 53 potentially eligible studies underwent full-text review. Thirty-seven papers were excluded: 2 due to review design, 21 did not have CSC data, 12 had inadequate CSC data, and 2 had overlapping populations with included studies. Sixteen independent studies with a total of 135972 subjects were included in the final analysis \[[@B19]--[@B34]\].

3.2. Study Characteristics {#sec3.2}
--------------------------

The characteristics of the included studies are presented in [Table 1](#tab1){ref-type="table"}. Of which, 14 studies were published in peer-reviewed journals, while 2 were unpublished \[[@B32], [@B33]\]. One study was national, while others were regional. The number of examined people ranged from 1076 to 39908. Two studies were conducted in Bangladesh, one in Bhutan, four in India, five in Nepal, and four in Pakistan.

3.3. Methodological Quality {#sec3.3}
---------------------------

All 16 studies were categorized as having a low bias ([Table 2](#tab2){ref-type="table"}). Eight studies were conducted in single or multiple provinces (6 in rural and 2 in urban) and were not clear if it was representative of the national population. All studies reported the method of participant selection and the random sampling technique. The response rates in all studies were over 75.0% (median 92.25%).

3.4. Weighted Mean OR {#sec3.4}
---------------------

[Table 3](#tab3){ref-type="table"} shows the CSC by sex based on persons or eyes at different visual acuity levels. For CSC based on persons at the blind level, the CSC values were higher in males than in females in all except three studies. For studies reporting CSC based on other levels, similar phenomena were observed. The weighted mean OR by sample size was 1.5, 1.1, 1.4, and 1.1 at different levels, respectively.

3.5. Meta-Analysis and PAR {#sec3.5}
--------------------------

Meta-analysis was used for 15 studies. The meta-analysis of CSC by sex on a person basis (visual acuity \<3/60) showed a pooled OR of 1.46 (95% CI: 1.23--1.75) for males use of cataract surgery compared with females ([Figure 2](#fig2){ref-type="fig"}). The heterogeneity was significant (*P* \< 0.001; *I*^2^ = 67.6%), and a random effect model was adopted. Results were similar for the meta-analysis of CSC by sex on a person basis at a visual acuity \<6/18, with a pooled OR of 1.14 (95% CI: 1.05--1.24) with no significant heterogeneity among studies (*P*=0.349; *I*^2^ = 10.4%) ([Figure 3](#fig3){ref-type="fig"}). Regarding the CSC on an eye basis at visual acuity \<3/60, the associations were statistically significant, with a pooled OR of 1.40 (95% CI: 1.16--1.70) ([Figure 4](#fig4){ref-type="fig"}). Only 5 studies were available for meta-analysis of CSC on an eye basis at visual acuity \<6/18, and the pooled OR was not significant due to substantial heterogeneity among studies ([Figure 5](#fig5){ref-type="fig"}).

Subgroup analyses by design and location types produced similar results as the primary analyses (Figures [6](#fig6){ref-type="fig"}[](#fig7){ref-type="fig"}[](#fig8){ref-type="fig"}[](#fig9){ref-type="fig"}[](#fig10){ref-type="fig"}[](#fig11){ref-type="fig"}--[12](#fig12){ref-type="fig"}). Further sensitivity analyses that omitted one study at a time and calculated the pooled ORs for the remaining studies yielded consistent results (Figures [13](#fig13){ref-type="fig"} and [14](#fig14){ref-type="fig"}). There was no evidence of publication bias, as indicated by nonsignificant Begg\'s tests (*P*=0.488) and Egger\'s tests (*P*=0.173) in persons at VA \<3/60. The values of ARP at a person and eye basis were 6.28% and 7.48%, respectively.

4. Discussion {#sec4}
=============

This study first provides a summary of gender inequity in CSC in South Asia with 16 eligible including 5 countries. Most studies were performed in subnational regions using the RAAB design. Our results demonstrated that the female gender remains a significant barrier to the access of cataract surgery in South Asia, with males having 1.46 odds of receiving cataract surgery compared to females per-person at blind VA. A very similar meta-analysis from India has been recently published in the British Journal of Ophthalmology. Prasad et al. reported that CSC was found to be 27% lower in women than men in India, and it could be improved by 13.4% in women if the gender gap in coverage is eliminated \[[@B35]\]. This is also supported by our findings, where women do not receive cataract surgery at the same rate as men do, and closing this gender gap may be a much-needed step.

Although gender inequity remains a significant problem in Nepal; however, it is not necessarily true for all programs. The pooled OR of CSC at blind VA was 1.09 (95% CI: 0.77--1.54) based on 5 studies in Nepal. Sherchan et al. reported that in the past 10 years, blindness prevalence, particularly due to cataract, has decreased and cataract surgical coverage has increased in the Lumbini Zone and Chitwan District. Cataract and other surgical services are equitably distributed by age and sex throughout all districts in the service area \[[@B23]\]. In another example in Nepal, Thapa et al. reported that the cataract surgical coverage was 90.36% and was high in females and illiterate subjects in Bhaktapur \[[@B22]\]. These are all indicators that cataract intervention programs have been successful in these areas.

Our study confirmed and extended previous efforts on the gender disparities in eye disease/service. In 2001, Abou-Gareeb et al. \[[@B10]\] reported that the prevalence of blindness was higher in females compared to males, which did not analyze the cataract blindness. In 2009, Lewallen et al. reported that the pooled OR of CSC was 1.71 (95%CI: 1.48--1.97) based on persons at visual acuity \<6/60 \[[@B11]\]. However, these studies were limited by the inclusion of relatively outdated studies, with only a few studies from South Asia, and did not access raw data from their selected studies. Furthermore, the studies only used CSC person data at a visual acuity \<6/60 with various methods. In Latin America, Cart et al. \[[@B15]\] reported that gender did not play a significant role in access to cataract surgery. Our results were consistent with the analyses by Lewallen et al. \[[@B11], [@B12]\]. The strength of this analysis lies in the inclusion of a large number of studies from 5 countries, use of raw data, multiple analyses at different levels, and use of data that reflect current situations with respect to cataract surgery programs and access. Furthermore, we observed progress in alleviating gender inequity. It was estimated that cataract blindness could have been reduced to a rate of 12.5% in 2000 and 10.8% in 2008 if the males and females had the same CSC rates \[[@B11], [@B12]\]. Our results suggest that this figure may have been reduced to 6.28% in South Asia, indicating persistent efforts aimed at reducing the gender gap in eye care access are warranted.

Possible explanations for the gender inequity in CSC are related to the social, economic, and cultural differences between males and females \[[@B12], [@B36]\]. The use of cataract surgical services was reported to be associated with the cost of cataract surgery and transportation, awareness of cataract surgery, and community-based education \[[@B37]\]. Females generally had higher illiteracy rates, especially amongst the elderly, reducing access to such information regarding treatment. It has been reported that the literacy of the affected person and their family members was a key predictor of receiving cataract surgery in South India \[[@B31]\]. Females may also have fewer financial resources to pay for eye care and transportation to hospitals compared to their male family counterparts. Various epidemiology studies confirmed the higher prevalence of cataract in females compared to males \[[@B10], [@B38]\]. The circumstances in South Asia are complex and may be related to work role, education, and economic decision-making power. Further research is needed to better understand these phenomena.

Our results have major implication in planning blindness prevention programs. Equal access to eye care could substantially reduce blindness in South Asian countries. For cataract programs, it was estimated that the proportion of cataract surgery performed in females should be 60%--65% to produce an equal CSC between genders \[[@B10]\]. Action should be taken to reduce the gender gap in CSC to achieve the blindness prevention target set out by the GAP. An anecdotal study in Pakistan showed that the following interventions can effectively address the barrier to cataract surgery: reducing surgical cost, flexibility of service time, reducing the need for accompanying family members, providing transport, and educational outreach \[[@B39]\]. As women have a higher incidence of cataract and longer life expectancy, a higher rate of cataract surgery in female populations should be emphasized in cataract programs. The female cataract surgery account for 59%--66% of all cataract surgery in developed countries such as France and Sweden \[[@B40], [@B41]\]. Therefore, strategies aimed at increasing eye care service utilization, especially access of cataract surgery by women, are warranted.

This study has several limitations. First, most of the included studies were not designed specifically to assess the gender inequity in access to cataract surgery. The risk and bias of these studies were not evaluated; however, as the majority was of the RAAB format using standardized methodologies and the results were considered to be reliable. Second, CSCs were calculated based on all operated eyes; however, those receiving the surgery may not necessarily have had visual impairment preoperatively. Nevertheless, our findings were robust as sensitivity analysis yielded virtually unchanged results. Third, most studies were performed in subnational areas, and for large countries such as India, substantial variations may exist across regions. Fourth, this study only included five countries in South Asia, including India, Pakistan, Nepal, Bangladesh, and Bhutan. Sri Lanka and Maldives were not included because relevant studies conducted in these two countries were fewer and they did not meet the inclusion criteria. Finally, the CSC does not take surgical quality into account. In a rural Southern Indian population, it was reported that 7.2% of blindness was iatrogenic and attributed to cataract surgery. Gender gaps in CSC and cataract surgical outcomes should be evaluated in further cataract program analyses.

5. Conclusions {#sec5}
==============

In summary, the female gender remains a significant barrier to the access of cataract surgery in South Asia. We propose that once the female population achieves an equal CSC compared to males, the prevalence of cataract blindness can be reduced by around 6.28% in this region. Factors impeding females\' access to cataract surgery should be taken into account when planning blindness prevention programs, and CSC targets should be relative to gender. More efforts are needed to increase the utilization of eye care services in South Asia, and especially the female population\'s access to cataract surgery.

1. Search Strategy {#secA}
==================

"Cataract Extraction" \[Mesh\]"Phacoemulsification" \[Mesh\]"Lens Implantation, Intraocular" \[Mesh\]"Phakic Intraocular Lenses" \[Mesh\]Phacoemulsification \[Title/Abstract\]"Extracapsular cataract extraction" \[Title/Abstract\]"Manual small incision cataract surgery" \[Title/Abstract\]Phaco \[Title/Abstract\] OR Phako \[Title/Abstract\]ECCE \[All Fields\] OR MSICS \[All Fields\] OR SICS \[All Fields\]Intraocular lens*∗*\[All Fields\] OR intraocular lens*∗*\[All Fields\] OR IOL*∗*\[All Fields\]"cataract surgical coverage" \[All Fields\]"cataract surgery coverage" \[All Fields\]CSC \[All Fields\]\#1OR \#2 OR \#3 OR \#4 OR \#5 OR \#6 OR \#7OR \#8 OR \#9 OR \#10 OR \#11 OR \#12 OR \#13"Sex Factors" \[Mesh\]Gender \[All Fields\]Female \[All Fields\]Sex \[All Fields\]\#15 OR \#16 OR \#17 OR \#18"Epidemiology" \[Mesh\]"Cross-Sectional Studies" \[Mesh\]Epidemiology \[All Fields\]"population-based study" \[All Fields\]\#20 OR \#21 OR \#22 OR \#23South Asia \[All Fields\]India \[All Fields\] OR Pakistan \[All Fields\] OR Bangladesh \[All Fields\] OR Maldives \[All Fields\] OR Sri Lanka \[All Fields\] OR Bhutan \[All Fields\] OR Nepal \[All Fields\]\#25 OR \#26\#14 AND \#19 AND \#24 AND \#27
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###### 

Characteristics of studies included in the meta-analysis.

  First author                     Published year   Country      Design        Survey year   Location type        No. examined   Age group   Response rate (%)
  -------------------------------- ---------------- ------------ ------------- ------------- -------------------- -------------- ----------- -------------------
  Guruprasad et al. \[[@B19]\]     2013             India        PBCSS, RAAB   2011          Subnational, both    2907           ≥50         95.30
  Shaikh and Aziz \[[@B20]\]       2005             Pakistan     PBCSS, RAAB   2003          Subnational, rural   1076           ≥50         93.60
  Lepcha et al. \[[@B21]\]         2013             Bhutan       PBCSS, RAAB   2009          Subnational, both    4046           ≥50         98.70
  Thapa et al. \[[@B22]\]          2011             Nepal        PBCSS         After 2001    Subnational, urban   4003           ≥40         83.39
  Sherchan et al. \[[@B23]\]       2010             Nepal        PBCSS         2006          Subnational, rural   5138           ≥50         86.80
  Sapkota et al. \[[@B24]\]        2010             Nepal        PBCSS, RAAB   2006          Subnational, rural   4717           ≥50         85.30
  Murthy et al. \[[@B25]\]         2009             India        PBCSS         2007          Subnational, both    4738           ≥50         91.90
  Jadoon et al. \[[@B26]\]         2007             Pakistan     PBCSS         2002          Subnational, both    16570          ≥30         95.50
  Anjum et al. \[[@B27]\]          2006             Pakistan     PBCSS, RAAB   2004          Subnational, rural   1549           ≥50         96.80
  Sapkota et al. \[[@B28]\]        2006             Nepal        PBCSS, RAAB   2002          Subnational, rural   5002           ≥45         85.30
  Wadud et al. \[[@B29]\]          2006             Bangladesh   PBCSS, RAAB   2005          Subnational, rural   4868           ≥50         91.90
  Haider et al. \[[@B30]\]         2003             Pakistan     PBCSS, RAAB   2000          Subnational, both    1505           ≥50         94.10
  Nirmalan et al. \[[@B31]\]       2003             India        PBCSS         2000          Subnational, both    15265          ≥50         92.30
  Khan and Jadoon \[[@B32]\]       2015             Pakistan     PBCSS, RAAB   2015          Subnational, urban   3084           ≥50         96.80
  Sapkota and Limburg \[[@B33]\]   2012             Nepal        PBCSS, RAAB   2006--2010    National             39908          ≥50         92.20
  Muhit et al. \[[@B34]\]          2016             Bangladesh   PBCSS, RAAB   2010--2012    Subnational, both    21596          ≥50         86.70

PBCSS: population-based cross-sectional study; RAAB: rapid assessment of avoidable blindness or rapid assessment of cataract surgical service.

###### 

Risk of bias of individual studies.

  First author                     Published year   External validity   Internal validity   Summary item                                             
  -------------------------------- ---------------- ------------------- ------------------- -------------- ----- ----- ----- ----- ----- ----- ----- ------------------
  Guruprasad et al. \[[@B19]\]     2013             Yes                 Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Shaikh and Aziz \[[@B20]\]       2005             No                  Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Lepcha et al. \[[@B21]\]         2013             Yes                 Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Thapa et al. \[[@B22]\]          2011             No                  Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Sherchan et al. \[[@B23]\]       2010             No                  Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Sapkota et al. \[[@B24]\]        2010             No                  Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Murthy et al. \[[@B25]\]         2009             Yes                 Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Jadoon et al. \[[@B26]\]         2007             Yes                 Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Anjum et al. \[[@B27]\]          2006             No                  Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Sapkota et al. \[[@B28]\]        2006             No                  Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Wadud et al. \[[@B29]\]          2006             No                  Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Haider et al. \[[@B30]\]         2003             Yes                 Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Nirmalan et al. \[[@B31]\]       2003             Yes                 Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Khan and Jadoon \[[@B32]\]       2015             No                  Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Sapkota and Limburg \[[@B33]\]   2012             Yes                 Yes                 Yes            Yes   Yes   Yes   Yes   Yes   Yes   Yes   Low risk of bias
  Muhit et al. \[[@B34]\]          2016             Yes                 Yes                 Yes            Yes   Yes   Yes   Yes   Yes   No    Yes   Low risk of bias

1 = was the study\'s target population a close representation of the national population in relation to relevant variables? 2 = was the sampling frame a true or close representation of the target population? 3 = was some form of random selection used to select the sample, OR; was a census undertaken? 4 = was the likelihood of nonresponse bias minimal? 5 = were data collected directly from the subjects? 6 = was an acceptable case definition used in the study? 7 = was the study instrument that measured the parameter of interest shown to have reliability and validity? 8 = was the same mode of data collection used for all subjects? 9 = was the length of the shortest prevalence period for the parameter of interest appropriate? 10 = were the numerator and denominator for the parameter of interest appropriate?

###### 

Cataract surgical coverage (CSC) in male and female at different visual acuity level.

  First author                     Published year   CSC (person, VA \<3/60)   CSC (person, VA \<6/18)   CSC (eyes, VA \<3/60)   CSC (eyes, VA \<6/18)                                                           
  -------------------------------- ---------------- ------------------------- ------------------------- ----------------------- ----------------------- --------- ----- ------ --------- ----- ------ --------- -----
  Guruprasad et al. \[[@B19]\]     2013             84.6                      79.7                      1.4                     NA                      NA        ---   72.1   67.8      1.2   NA     NA        ---
  Shaikh and Aziz \[[@B20]\]       2005             NA                        NA                        ---                     NA                      NA        ---   51.9   47.8      1.2   NA     NA        ---
  Lepcha et al. \[[@B21]\]         2013             77.8                      67.7                      1.7                     NA                      NA        ---   61.5   51.3      1.5   NA     NA        ---
  Thapa et al. \[[@B22]\]          2011             85.3                      93.9                      0.4                     NA                      NA        ---   NA     NA        ---   NA     NA        ---
  Sherchan et al. \[[@B23]\]       2010             61.7                      70.8                      0.7                     NA                      NA        ---   NA     NA        ---   NA     NA        ---
  Sapkota et al. \[[@B24]\]        2010             39.3                      35.8                      1.2                     NA                      NA        ---   NA     NA        ---   NA     NA        ---
  Murthy et al. \[[@B25]\]         2009             75.5                      69.7                      1.3                     NA                      NA        ---   NA     NA        ---   NA     NA        ---
  Jadoon et al. \[[@B26]\]         2007             79.6                      74.9                      1.3                     44.6                    42.8      1.1   64.5   58.4      1.3   42.8   38.6      1.2
  Anjum et al. \[[@B27]\]          2006             68.9                      51.6                      2.1                     NA                      NA        ---   49.5   41.3      1.4   NA     NA        ---
  Sapkota et al. \[[@B28]\]        2006             68.1                      52.6                      1.9                     NA                      NA        ---   NA     NA        ---   NA     NA        ---
  Wadud et al. \[[@B29]\]          2006             63.5                      59.0                      1.2                     34.5                    36.4      0.9   34.6   34.9      1.0   17.4   18.7      0.9
  Haider et al. \[[@B30]\]         2003             92.8                      73.9                      4.6                     53.3                    45.5      1.4   75.7   63.7      1.8   39.1   33.1      1.3
  Nirmalan et al. \[[@B31]\]       2003             74.4                      60.5                      1.9                     NA                      NA        ---   67.7   46.8      2.4   NA     NA        ---
  Khan and Jadoon \[[@B32]\]       2015             92.5                      92.6                      1.0                     75.5                    71.5      1.2   77.0   75.2      1.1   62.0   54.0      1.4
  Sapkota and Limburg \[[@B33]\]   2012             87.6                      82.9                      1.5                     55.7                    53.5      1.1   68.9   65.7      1.2   40.0   38.8      1.1
  Muhit et al. \[[@B34]\]          2016             76.6                      64.3                      1.8                     35.1                    30.5      1.2   61.5   49.7      1.6   20.1   21.3      0.9
  Overall weighted mean                                                       **1.5**                                                                   **1.1**                **1.4**                **1.1**    

OR, odds ratio; NA, not available; VA, visual acuity.

[^1]: Academic Editor: Nóra Szentmáry
